ANDA 213720, held by Alkem Labs Ltd. Amphetamine Sulfate.
As of Nov 16, 2026, ANDA 213720 (Amphetamine Sulfate), held by Alkem Labs Ltd, was first approved by FDA on Oct 27, 2020, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 27, 2020 | Original application | Approved | None posted |
| Amphetamine Sulfate5MG · tablet;oral | Amphetamine Sulfate | Rx |
| Amphetamine Sulfate10MG · tablet;oral | Amphetamine Sulfate | Rx |
| Aug 20, 2025 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 10, 2024 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 25, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 27, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters